Med Life S.A. (BVB:M)
11.76
+0.04 (0.34%)
At close: Mar 4, 2026
Med Life Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 3,173 | 2,716 | 2,210 | 1,795 | 1,427 | Upgrade
|
| Other Revenue | 12.94 | 8.85 | 11.3 | 14.12 | 10.36 | Upgrade
|
| Revenue | 3,186 | 2,724 | 2,222 | 1,810 | 1,438 | Upgrade
|
| Revenue Growth (YoY) | 16.92% | 22.63% | 22.78% | 25.87% | 32.29% | Upgrade
|
| Cost of Revenue | 1,603 | 1,394 | 1,160 | 977.47 | 674.49 | Upgrade
|
| Gross Profit | 1,582 | 1,331 | 1,061 | 832.08 | 763.09 | Upgrade
|
| Selling, General & Admin | 937 | 853.23 | 694.63 | 519.15 | 415.44 | Upgrade
|
| Other Operating Expenses | 192.99 | 74.14 | 75.09 | 61.45 | 56.77 | Upgrade
|
| Operating Expenses | 1,415 | 1,188 | 969.8 | 737.85 | 585.97 | Upgrade
|
| Operating Income | 167.29 | 142.82 | 91.52 | 94.23 | 177.12 | Upgrade
|
| Interest Expense | -96.66 | -95.58 | -76.31 | -34.32 | -21.6 | Upgrade
|
| Interest & Investment Income | 2.29 | 2.18 | 3.42 | 1.26 | 0.15 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -1.35 | -9.69 | -4.08 | -9.17 | Upgrade
|
| Other Non Operating Income (Expenses) | -46.05 | -6.59 | -4.64 | -7.53 | -5.82 | Upgrade
|
| EBT Excluding Unusual Items | 26.87 | 41.48 | 4.3 | 49.56 | 140.69 | Upgrade
|
| Merger & Restructuring Charges | - | -1.77 | - | - | - | Upgrade
|
| Asset Writedown | -7.71 | -0.65 | - | - | -5.27 | Upgrade
|
| Pretax Income | 19.16 | 39.07 | 4.3 | 49.56 | 135.42 | Upgrade
|
| Income Tax Expense | 23.11 | 22.32 | 8.46 | 12.12 | 22.51 | Upgrade
|
| Earnings From Continuing Operations | -3.95 | 16.75 | -4.16 | 37.43 | 112.91 | Upgrade
|
| Minority Interest in Earnings | 15.55 | 8.28 | 7.85 | -5.26 | -10.3 | Upgrade
|
| Net Income | 11.6 | 25.04 | 3.68 | 32.17 | 102.61 | Upgrade
|
| Net Income to Common | 11.6 | 25.04 | 3.68 | 32.17 | 102.61 | Upgrade
|
| Net Income Growth | -53.67% | 579.53% | -88.55% | -68.65% | 80.97% | Upgrade
|
| Shares Outstanding (Basic) | 531 | 531 | 531 | 531 | 531 | Upgrade
|
| Shares Outstanding (Diluted) | 531 | 531 | 531 | 531 | 531 | Upgrade
|
| Shares Change (YoY) | -0.06% | -0.04% | 0.05% | -0.02% | 0.30% | Upgrade
|
| EPS (Basic) | 0.02 | 0.05 | 0.01 | 0.06 | 0.19 | Upgrade
|
| EPS (Diluted) | 0.02 | 0.05 | 0.01 | 0.06 | 0.19 | Upgrade
|
| EPS Growth | -53.51% | 577.92% | -88.56% | -68.64% | 80.42% | Upgrade
|
| Free Cash Flow | 2.56 | 48.89 | -17.81 | 35.51 | 135.87 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.09 | -0.03 | 0.07 | 0.26 | Upgrade
|
| Gross Margin | 49.67% | 48.84% | 47.77% | 45.98% | 53.08% | Upgrade
|
| Operating Margin | 5.25% | 5.24% | 4.12% | 5.21% | 12.32% | Upgrade
|
| Profit Margin | 0.36% | 0.92% | 0.17% | 1.78% | 7.14% | Upgrade
|
| Free Cash Flow Margin | 0.08% | 1.79% | -0.80% | 1.96% | 9.45% | Upgrade
|
| EBITDA | 452.19 | 305.65 | 205.68 | 183.71 | 245.58 | Upgrade
|
| EBITDA Margin | 14.19% | 11.22% | 9.26% | 10.15% | 17.08% | Upgrade
|
| D&A For EBITDA | 284.9 | 162.82 | 114.16 | 89.48 | 68.45 | Upgrade
|
| EBIT | 167.29 | 142.82 | 91.52 | 94.23 | 177.12 | Upgrade
|
| EBIT Margin | 5.25% | 5.24% | 4.12% | 5.21% | 12.32% | Upgrade
|
| Effective Tax Rate | 120.61% | 57.12% | 196.87% | 24.47% | 16.62% | Upgrade
|
| Revenue as Reported | 3,186 | 2,724 | 2,222 | 1,810 | 1,438 | Upgrade
|
| Advertising Expenses | - | 47.27 | 37.02 | 26.66 | 15.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.